Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|January 20, 2021
Endogenous Retroviruses in Nervous System DisordersVictoria Gröger, Alexander Emmer, Martin S Staege, et al.
Molecular Biology Reports|February 2, 2019
Identification of human endogenous retrovirus transcripts in Hodgkin Lymphoma cellsMarie Barth, Victoria Gröger, Holger Cynis, et al.
Molecular Neurodegeneration|July 2, 2016
Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challengesHolger Cynis, Jeffrey L Frost, Helen Crehan, et al.
Bioscience Reports|July 26, 2017
N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activityAstrid Kehlen, Monique Haegele, Livia Böhme, et al.
Acta Neuropathologica|June 24, 2009
Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse modelOliver Wirths, Henning Breyhan, Holger Cynis, et al.
Amino Acids|January 25, 2013
A quantitative analysis of spontaneous isoaspartate formation from N-terminal asparaginyl and aspartyl residuesBert H-O Güttler, Holger Cynis, Franziska Seifert, et al.
International Journal of Molecular Sciences|August 12, 2022
Immunogenicity of the Envelope Surface Unit of Human Endogenous Retrovirus K18 in MiceVictoria Ilse, Rebekka Scholz, Michael Wermann, et al.
Pageof 6